| Literature DB >> 18518822 |
Peter Tontonoz1, Bruce M Spiegelman.
Abstract
The nuclear receptor PPARgamma is a ligand-activated transcription factor that plays an important role in the control of gene expression linked to a variety of physiological processes. PPARgamma was initially characterized as the master regulator for the development of adipose cells. Ligands for PPARgamma include naturally occurring fatty acids and the thiazolidinedione (TZD) class of antidiabetic drugs. Activation of PPARgamma improves insulin sensitivity in rodents and humans through a combination of metabolic actions, including partitioning of lipid stores and the regulation of metabolic and inflammatory mediators termed adipokines. PPARgamma signaling has also been implicated in the control of cell proliferation, atherosclerosis, macrophage function, and immunity. Here, we review recent advances in our understanding of the diverse biological actions of PPARgamma with an eye toward the expanding therapeutic potential of PPARgamma agonist drugs.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18518822 DOI: 10.1146/annurev.biochem.77.061307.091829
Source DB: PubMed Journal: Annu Rev Biochem ISSN: 0066-4154 Impact factor: 23.643